Bioanalysis - Discovery, Preclinical And Clinical Brochure

Comprehensive bioanalytical support is key at every stage of product development, from discovery to preclinical studies, as well as all phases of clinical development. The experienced scientists at Charles River develop, validate and apply quantitative bioanalytical methods for the determination of pharmaceutical compounds ranging from small molecules to larger proteins, giving you the exact bioanalytical support you need to quickly and efficiently accelerate your products.

Our laboratories have the latest instrumentation to measure drug and metabolite concentrations in biological matrices, such as plasma, serum, cerebrospinal fluid (CSF), urine and tissues, using a wide range of techniques and technology platforms. This variety of advanced equipment ensures that we have the capacity to support you with rapid lead-in times in order to meet critical deadlines.